Skip to content

An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults

An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06105723
Enrollment
1000
Registered
2023-10-30
Start date
2024-01-01
Completion date
2026-09-30
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ageing Well

Keywords

Aging, Functional ability, Care model, Community-dwelling

Brief summary

The goal of this clinical trial is to provide a scientific evaluation on the effects of a protocol-driven Pathway to Healthy Aging (Path-HA) Program on promoting the health-related quality of life and functional abilities of older adults who are at risk of accelerated aging in the community. Participants will be randomized to one of the two study arms: 1) the intervention group to receive a 14-week Path-HA care intervention; and 2) the control group with no Path-HA care intervention.

Detailed description

This assessor-blind, randomized controlled trial evaluates the effects of the Pathway to Healthy Aging Program, which is based on the WHO ICOPE model, on the promotion of the health-related quality of life (primary outcome) as well as functional abilities (secondary outcomes) as defined by the WHO-ICOPE among community-dwelling older adults with accelerated aging. Six health domains including locomotor function, vitality, psychological function, cognitive function, social functions, and overall health-related quality of life are measured. A total of 1000 participants will be recruited. Outcome evaluation takes place at baseline, upon the completion of the care program, and at 6 months thereafter to allow the detection of long-term program benefits. In-depth individual interviews will be conducted to solicit the participants' experience and perceived benefits of the program.

Interventions

BEHAVIORALPathway to Healthy Aging care

The ICOPE-based personalized care planning comprises two home visits. In 1st visit, a comprehensive assessment proposed by the WHO-ICOPE model is conducted to identify eight possible health problems including malnutrition, reduced physical fitness, fall risk, cognitive decline, insomnia, pain, psychological distress and social loneliness. After health problem identification, each participant receives a personalized care prescription. 2nd visit adopts a goal-oriented empowerment 3-step cycle to personalize the care planning: 1) communicating assessment results to increase healthy self-awareness; 2) supporting setting person-directed goals to address health problems; 3) identifying health actions and personalizing goal setting to participants' contexts. The 12-week healthy aging empowerment comprises three core activities for healthy aging promotion, including interactive health education, health message broadcasts, and three case conferences for goal monitoring and health counseling.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 1\) aged 60 or above, * 2\) with at least two risk factors of accelerating aging defined as including reduced physical functioning, malnutrition, depressed mood, loneliness, poor health perception, and presence of geriatric symptoms (e.g. insomnia, pain, etc), based on their health screening results, * 3\) community-dwelling, * 4\) communicable to engage in health education activity.

Exclusion criteria

* 1\) any who is not at or at only one risk factor of accelerating aging, * 2\) any who has problems in communicating with the research team.

Design outcomes

Primary

MeasureTime frameDescription
Health-related quality of lifeChanges from baseline to 3-month and 9-month post-interventionMeasured by the EQ-5D-5L questionnaire (scores range from -0.59 to 1.0), with a higher score indicating better quality of life.

Secondary

MeasureTime frameDescription
Hand grip strengthChanges from baseline to 3-month and 9-month post-interventionMeasured by hand-held dynamometer in unit of KG. A larger count indicates a greater grip strength.
Balancing functionChanges from baseline to 3-month and 9-month post-interventionMeasured by the Timed Up and Go Test in unit of second. A shorter completion time indicates better mobility and balance.
Physical mobility levelChanges from baseline to 3-month and 9-month post-interventionMeasured by the Short Physical Performance Battery (scores range from 0 to 12), with higher scores indicating better physical performance and better mobility functioning.
Sarcopenia riskChanges from baseline to 3-month and 9-month post-interventionMeasured by Sarcopenia and calf circumference scale (SARC-CalF scale). The score ranges from 0 to 20 points, with a score ≥ 11 points suggestive of sarcopenia.
Nutritional statusChanges from baseline to 3-month and 9-month post-interventionMeasured by the Mini Nutritional Assessment (scores range from 0 to 30), with a lower score indicating a higher risk of malnutrition.
Sleep qualityChanges from baseline to 3-month and 9-month post-interventionMeasured by Insomnia Severity Index questionnaire (scores range from 0 to 28), with higher scores indicating greater severity of insomnia.
Depressed moodChanges from baseline to 3-month and 9-month post-interventionMeasured by the 15-item Geriatric Depression Scale (scores range from 0 to 15), with a higher score indicating a higher risk of depression.
Cognitive functionsChanges from baseline to 3-month and 9-month post-interventionMeasured by the 5-minute Montreal Cognitive Assessment Test (scores range from 0 to 30). A raw score of \< 25 in well-educated persons (education \> 12 years) or a raw score of \< 23 in less-educated persons (education ≤ 12 years) is defined as impaired cognition.
Subjective memoryChanges from baseline to 3-month and 9-month post-interventionMeasured by Memory Inventory for the Chinese (scores range from 0 to 108), with higher scores indicating more severe subjective memory loss.
LonelinessChanges from baseline to 3-month and 9-month post-interventionMeasured by The 3-Item UCLA Loneliness Scale (scores range from 3 to 9), with higher scores suggesting a higher level of loneliness.
Social connectednessChanges from baseline to 3-month and 9-month post-interventionMeasured by The 8-item version of Social Connectedness Scale (scores range from 8 to 48), with a higher score indicating a greater sense of social connectedness.

Countries

Hong Kong

Contacts

PRINCIPAL_INVESTIGATORDoris Sau Fung YU, PhD

The University of Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026